Streptococcus and Tics
Another Brick in the Wall?
Citation Manager Formats
Make Comment
See Comments

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Tourette syndrome (TS) is a neurodevelopmental condition characterized by multiple tics. Tics are the most common hyperkinetic manifestations in youth, often causing physical discomfort, emotional distress, social difficulties, and interference with education and desired activities. It has been established that tic severity does not remain constant, but fluctuates over time in a typical waxing and waning pattern. Moreover, patients with TS frequently present with challenging neuropsychiatric comorbidities, most notably obsessive-compulsive disorder (OCD) and attention-deficit/hyperactivity disorder (ADHD).1 Despite its epidemiologic relevance and its potential effect on patients' health-related quality of life, there are still several crucial known unknowns about TS. Specifically, the clinical management of TS continues to be difficult, as the genetics, neurophysiology, and neuropathology of this disorder are largely unknown.2 As in most neuropsychiatric conditions, it is thought that both genetic and environmental factors are likely to play a role as etiologic mechanisms: the commonly agreed view is that “the genes load the gun and the environment pulls the trigger.” Among the environmental factors, prenatal and perinatal difficulties, as well as hormonal and immunologic contributions, have emerged as promising candidates. Over the past 2 decades, group A Streptococcus (GAS) has been investigated as a possible environmental agent associated with tic disorders. Isolated clinical observations, interpreted in the light of the established motor presentation of Sydenham chorea, have suggested the inclusion of tic disorders as a collateral feature within a group of conditions called pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS).3 PANDAS are currently incorporated in the broader concept of pediatric acute neuropsychiatric syndromes.4 The link between Streptococcus and tics is the subject of intense debate, as a few longitudinal clinical studies including mixed populations of PANDAS and chronic tic disorders found that tic exacerbations were unrelated to GAS infection in the majority of cases.5,6 Interestingly, the results of a case–control study of a large primary care database also led to arguing against this association.7
Footnotes
Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the editorial.
See page 570
- © 2021 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Nicole Sur and Dr. Mausaminben Hathidara
► Watch
Related Articles
Topics Discussed
Alert Me
Recommended articles
-
Null Hypothesis
Association of Group A Streptococcus Exposure and Exacerbations of Chronic Tic DisordersA Multinational Prospective Cohort StudyDavide Martino, Anette Schrag, Zacharias Anastasiou et al.Neurology, February 10, 2021 -
Article
A multicenter examination and strategic revisions of the Yale Global Tic Severity ScaleJoseph F. McGuire, John Piacentini, Eric A. Storch et al.Neurology, April 13, 2018 -
Views & Reviews
The 5 Pillars in Tourette Syndrome Deep Brain Stimulation Patient SelectionPresent and FutureDavide Martino, Wissam Deeb, Joohi Jimenez-Shahed et al.Neurology, February 16, 2021 -
Articles
The Gilles de la Tourette Syndrome–Quality of Life Scale (GTS-QOL)Development and validationA. E. Cavanna, A. Schrag, D. Morley et al.Neurology, October 27, 2008